Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-11

Clinical Trial Update: Treating Spinal Cord Injury With Early Normobaric Hyperoxia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes evaluating early normobaric hyperoxia for traumatic spinal cord injury, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Traumatic Spinal Cord Injuries | Phase 2 | Status: NOT_YET_RECRUITING